CLDN4 as Pan-Cancer Prognostic Marker and its Effects on Immune Infiltration in the Tumor Microenvironment (Yi Xu, Yihui Gu, Yang Shen, M.D., Ph.D, & Wen Feng, MD , Trans.). (2024). Human Biology, 94(1), 406-415. https://www.humbiol.org/Home/article/view/21